Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) observed trading -80.26% off 52-week high price. On the other end, the stock has been noted 38.57% away from low price over the last 52-weeks. The stock disclosed a move of 6.35% away from 50 day moving average and -39.63% away from 200 day moving average. Moving closer, we can see that shares have been trading 9.21% off 20-day moving average. It has market cap of $159.78M .
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) released that the compensation committee of the company’s board of directors granted three new employees the option to purchase an aggregate of 11,000 shares of the company’s common stock, at a per share exercise price of $5.82, the closing trading price on July 8, 2019, and restricted stock units to acquire 5,500 shares of the company’s common stock. The stock options and restricted stock units vest over four years and were granted pursuant to the Adamas Pharmaceuticals, Inc. 2016 Inducement Plan, which was approved by the company’s board of directors in March 2016 under Rule 5653(c)(4) of the Nasdaq Global Market for equity grants to induce new employees to enter into employment with the company.
About Adamas Pharmaceuticals, Inc.
Adamas’ goal is to create and commercialize a new generation of medicines intended to lessen the burden of chronic neurologic diseases on patients, caregivers and society using its deep understanding of time-dependent biology. The Company is focused on the commercialization of GOCOVRI® (amantadine) extended release capsules, the first and only FDA-approved medicine for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications. The Company also continues to deliver differentiated investigational programs, including ADS-5102 in development for the treatment of walking impairment in patients with multiple sclerosis.
The USA based company Adamas Pharmaceuticals moved with change of -3.00% to $5.82 with the total traded volume of 334483 shares in recent session versus to an average volume of 378.24K. The stock was observed in the 5 days activity at -6.13%. The one month performance of stock was 25.16%. ADMS’s shares are at -14.29% for the quarter and driving a -77.03% return over the course of the past year and is now at -31.85% since this point in 2018. Right now the stock beta is 1.66. The average volatility for the week and month was at 4.74% and 6.13% respectively. There are 27.45M shares outstanding and 26.78M shares are floated in market.
Category - Business
After many years in the market, Charles Frey dedicated all his time to write articles highlighting different financial problems. He has worked as financial analyst until his retirement. He is a well-known research director and portfolio manager for more than 5 years.
Charles holds a postgraduate degree in Software Engineering. ‘The stock market is filled with individuals who know the price of everything, but the value of nothing.’ Charles is a share market expert, being personally invested for over 6 years. He has been writing his entire life, and while he has made a career of business and finance reporting, he still enjoys writing short stories and poetry.
Address: 2520 North Van Buren Street, Wilmington, DE 19802, USA
Email: [email protected]
Zip code: 19802
Contact # 302-298-6858